Meropenem marketed for meningitis, intra-abdominal infection.
D000005:Abdomen / Q000382:microbiology; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D017277:Drug Approval; D006801:Humans; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D000077731:Meropenem; D013845:Thienamycins / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D013845:Thienamycins; D000077731:Meropenem